PINK1 and ovarian cancer: To evaluate the direct influence of PINK1 on the EMT in ovarian cancer, IHC assay for EMT markers (E-cadherin and vimentin) was performed, which indicated a decreased level of vimentin and an increased level of E-cadherin upon PINK1 knockdown (Fig. 6G, H).